Home/ Supplements/ Omega 3/ Fish Oil

Fish Oil

product on market Softgel Capsule Nature's Bounty Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health and managing triglyceride levels. Research indicates these nutrients contribute to overall heart function and cognitive support. The ingredient profile is generally recognized as safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Fish Oil
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
100
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2.5 Gram(s) (4% DV)
Cholesterol
15 mg (5% DV)
2400 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Vegetable Glycerin Contains Less Than 2% of
Claims

Label Claims — Verification

Unverified All Other
Unverified Approved Health
Info

Product Information

Directions for Use

Directions: For adults, take two (2) softgels two times daily, preferably with meals.

Warnings & Precautions

Contains fish (anchovy, mackerel, sardine) ingredients.

Formulation Notes

Fish Oil 1200 mg 360 mg of Omega-3

May reduce risk of coronary heart disease Heart health

Metadata

Product Details

DSLD Entry Date2020-12-26
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID241612
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.